SAM and folic acid prevent arsenic-induced oxidative and nitrative DNA damage in human lymphoblast cells by modulating expression of inflammatory and DNA repair genes. Chem Biol Interact. Boonma T, Navasumrit P, Parnlob V, Waraprasit S, Ruchirawat M. 2022 Jul 1;361:109965. doi: 10.1016/j.cbi.2022.109965. Epub 2022 Apr 28. PMID: 35490796.

01 Jul 2022
0
0

SAM and folic acid prevent arsenic-induced oxidative and nitrative DNA damage in human lymphoblast cells by modulating expression of inflammatory and DNA repair genes.
Boonma T, Navasumrit P, Parnlob V, Waraprasit S, Ruchirawat M.
Chem Biol Interact. 2022 Jul 1;361:109965. doi: 10.1016/j.cbi.2022.109965.
Epub 2022 Apr 28. PMID: 35490796.

Tags

Share this

Related Posts

Khatib, S. A., Ma, L., Dang, H., Forgues, M., Chung, J. Y., Ylaya, K., . . . Wang, X. W. (2022). Single-cell biology uncovers apoptotic cell death and its spatial organization as a potential modifier of tumor diversity in HCC. Hepatology, 76(3), 599-611. doi:10.1002/hep.32345
01 Sep 2022
0

Khatib, S. A., Ma, L., Dang, H., Forgues, M., Chung, J. Y., Ylaya, K., . . . Wang, X. W. (2022). Single-cell biology uncovers apoptotic cell death and its spatial organization as a potential modifier of tumor diversity in HCC. Hepatology, 76(3), 599-611. doi:10.1002/hep.32345

Khatib, S. A., Ma, L., Dang, H., Forgues, M., Chung, J. Y., Ylaya, K., . . . Wang, X. W. (2022). Single-cell biology uncovers apoptotic cell death and its spatial organization as a potential modifier of tumor diversity in HCC. Hepatology, 76(3), 599-611. doi:10.1002/hep.32345
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
New
20 Sep 2023
0
New

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More